Skip to main navigation Skip to search Skip to main content

Salutary effect of resveratrol on sepsis-induced myocardial depression

  • Lonneke Smeding
  • , Howard Leong-Poi
  • , Pingzhao Hu
  • , Yuexin Shan
  • , Jack J. Haitsma
  • , Eva Horvath
  • , Suleiman Furmli
  • , Hussain Masoom
  • , Jan Willem Kuiper
  • , Arthur S. Slutsky
  • , Thomas G. Parker
  • , Frans B. Plötz
  • , Claudia C. Dos Santos
  • University of Toronto
  • Vrije Universiteit Amsterdam
  • The Keenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, Ontario, Canada

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Objectives: We hypothesized that resveratrol administration would reverse sepsis-dependent downregulation of peroxisome proliferator activated receptor-γ coactivator 1α, preserve mitochondrial integrity, and rescue animals from sepsis-induced myocardial failure. Setting: Teaching hospital research laboratory. Interventions: Cecal ligation and puncture in mice was performed to induce sepsis. Mice that underwent cecal ligation and puncture were randomly assigned to receive resveratrol (30 mg/kg or 60 mg/kg) or vehicle 1 mL sodium chloride 0.9% subcutaneously in the scruff of the neck directly after surgery and at 16, 24, and 40 hrs, respectively. Measurements and Results: Forty-eight hrs after cecal ligation and puncture, cardiac performance was established using echocardiography. Mitochondrial integrity was evaluated with electron microscopy, and changes in gene expression were evaluated with microarray analysis. Survival at 48 hrs was just under 50% and comparable between groups. Myocardial contractile function significantly improved after resveratrol treatment. Resveratrol-treated mice developed focal areas of edema, whereas vehicle-treated mice developed significant, diffuse myocardial edema. Electron microscopy revealed widespread swollen mitochondria with ruptured outer membranes, autophagosomes, and vacuolation of the internal compartment, which were significantly attenuated in resveratrol-treated animals. Resveratrol treatment significantly increased cardiac expression of peroxisome proliferator-activated receptor-γ coactivator 1a. Microarray analysis revealed that resveratrol treatment resulted in upregulation of the peroxisome proliferator-activated receptor-γ coactivator gene set containing genes known to be regulated by this transcriptional coactivator. Our data strongly suggest that administration of resveratrol modulates bioenergy metabolism, substrate utilization, oxidative stress, and detoxification pathways associated with both mitochondrial and cardiac pathological conditions, but does not alter mortality from sepsis. Conclusions: The salutary effects of resveratrol on cecal ligation and puncture-induced myocardial dysfunction are associated with increased peroxisome proliferator-activated receptor-γ coactivator 1a abundance and function. Preservation of myocardial energy production capacity, prevention of secondary injury, mitigation of inflammation, and reversal of sepsis-induced myocardial remodeling are likely to underlie its beneficial effects. This however, does not result in improved survival. © 2012 by the Society of Critical Care Medicine and Lippincott Williams & Wilkins.
Original languageEnglish
Pages (from-to)1896-1907
JournalCritical care medicine
Volume40
Issue number6
DOIs
Publication statusPublished - Jun 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 7 - Affordable and Clean Energy
    SDG 7 Affordable and Clean Energy

Fingerprint

Dive into the research topics of 'Salutary effect of resveratrol on sepsis-induced myocardial depression'. Together they form a unique fingerprint.

Cite this